Pre‐clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice

Abstract

This is a proof-of-principle study demonstrating the creation of a cryopreservable megakaryocytic cell product which releases functional PLTs in vivo. Clinical development of such a product is currently being pursued for the treatment of thrombocytopenia in patients with hematological malignancies.